Significant correlation with clinical parameters (pathological stage, distant metastasis, lymph node status, perforation) was also noted, which is in line with a previous study suggesting that activation of the KRAS gene may be more prevalent and could be a significant prognostic factor in patients with early-stage cancer [30]. Here, KRAS is linked to cancer.